Jacobs Levy Equity Management, Inc Angion Biomedica Corp. Transaction History

Jacobs Levy Equity Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.72 - $2.96 $77,811 - $133,907	-45,239 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.35 - $9.95 $106,311 - $450,128	45,239 New	45,239 $131,000
Q3 2021 Nov 15, 2021	SELL	$9.31 - $13.25 $532,029 - $757,184	-57,146 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.02 - $17.83 $744,040 - $1.02 Million	57,146 New	57,146 $744,000

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.